Dr. med. Dominik Zieglgänsberger
Neurologie · Dept. III
Swiss Primary Hypersomnolence and Narcolepsy Cohort Study
Jan 1, 2021
Clinical Studies - Jan 1, 2021 - Dec 31, 2023
Completed
Project leader: Von Manitius Sigrid
Members: Zieglgänsberger Dominik, Gievers-Steinlein Bettina
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of AMG 334 in Migraine Prevention (ARISE-Study)
Jun 1, 2015To evaluate the effect of AMG 334 compared to placebo on the change from baseline in monthly migraine days, in subjects with episodic migraine
Clinical Studies - Jun 1, 2015 - Dec 31, 2017
Automatically Closed
Project leader: Flügel Dominique
Members: Zieglgänsberger Dominik, Müller Anna